“…[26][27][28] Recently, anolytes such as N-methyl phthalimide, [29,30] 9flurenonone, [31] benzothiadiazoles, [32] camphoquinone, [33] trimethyl-quinoxaline, [34,35] PTIO, [36] 4-benzoylpyridinium derivatives, [37,38] 2-methylbenzophenone [39] and viologen derivatives were developed. [40,41] However, most of these anolytes exhibited low cycle life, possibly due to poor (electro)chemical stability, when used in ONRFBs.…”